Reader Response: Effect of Ocrelizumab on Vaccine Responses in Patients With Multiple Sclerosis: The VELOCE Study
- PMID: 34032592
- DOI: 10.1212/WNL.0000000000011867
Reader Response: Effect of Ocrelizumab on Vaccine Responses in Patients With Multiple Sclerosis: The VELOCE Study
Comment in
-
Author Response: Effect of Ocrelizumab on Vaccine Responses in Patients With Multiple Sclerosis: The VELOCE Study.Neurology. 2021 May 4;96(18):870. doi: 10.1212/WNL.0000000000011868. Neurology. 2021. PMID: 34032593 No abstract available.
Comment on
-
Effect of ocrelizumab on vaccine responses in patients with multiple sclerosis: The VELOCE study.Neurology. 2020 Oct 6;95(14):e1999-e2008. doi: 10.1212/WNL.0000000000010380. Epub 2020 Jul 29. Neurology. 2020. PMID: 32727835 Free PMC article. Clinical Trial.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical